Openbookopenbook
Equity
Indo Global Exchange(IGEX)
USD --+0.00%
Reward42Moderate
Risk92High
📊50%Data
Revenue down 100% YoY
IGEX
+0.0 · +0.00%
USD · PINK
Indo Global Exchange | Healthcare
Earnings Deterioration
Market Cap:2.14M
ℹ️
Reward Rating
42
Moderate
Bottom 10% (model universe)
50% data coverage
ℹ️
Risk Rating
92
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on IGEX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Indo Global Exchange?

, a development stage company, focuses on providing financial market access to customers worldwide.

IGEX · Verdict

Moderate reward · high risk

IGEX has limited near-term tailwinds — cash flow and volatility weigh on the model output.

Based on 75% data coverage

IGEX · Verdict

What’s working & what to watch

Watchouts 4

  • Cash flow5/100

    Weak vs peers

  • Volatility5/100

    Weak vs peers

  • Profitability10/100

    0% return on equity

  • Balance sheet10/100

    Current ratio 0.92

Model-based scoring. For information only — not financial advice.

What is Indo Global Exchange?

, a development stage company, focuses on providing financial market access to customers worldwide. Its platform provides financial market access to approximately 30 equity exchanges for trading in securities and contract for differences. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.14M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Elevated volatility implies higher downside and expectation risk.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (42)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap2.14M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0012
52 Week Low0.0002
Last AnnualJuly
IPO DateN/A
IncorporatedUSA
Shares Outstanding7B
No. of EmployeesN/A
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta2.133
CurrencyUSD
Websitewww.igex.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.